Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,799.50
Bid: 1,796.00
Ask: 1,796.50
Change: 19.00 (1.07%)
Spread: 0.50 (0.028%)
Open: 1,784.00
High: 1,799.50
Low: 1,780.00
Prev. Close: 1,780.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MIDDAY BRIEFING: AstraZeneca Continues To Reject Pfizer

Tue, 13th May 2014 13:11

LONDON (Alliance News) - AstraZeneca Tuesday again rejected Pfizer's "opportunistic" GBP63 million takeover approach, as UK politicians grilled executives of both companies about the potential deal and what it will mean for the UK's pharmaceutical industry.

Crucially, AstraZeneca Chief Executive Pascal Soriot left the door open for a higher Pfizer approach, saying "it's impossible to say we would not accept any offer".

Pfizer is planning to sweeten its approach to AstraZeneca for a second time, raising it modestly from the current GBP50-a-share approach, Bloomberg reported, citing people with knowledge of the matter. The US company will likely wait until after the UK government hearings, Bloomberg quoted the people as saying.

UK politicians have little say over the outcome of the potential takeover unless they change the law, as the UK is governed by EU takeover laws which leave decisions to company shareholders and anti-trust regulators. However, Pfizer may not proceed with a formal deal if it meets with heavy opposition from the UK government.

In a statement, AstraZeneca said Pfizer was "making an opportunistic attempt to acquire a transformed AstraZeneca, without reflecting the value of its exciting pipeline." That came after Pfizer reiterated its eagerness to continue discussions with the British drugs giant, warning that it faced challenges if it remained independent.

The US company reiterated its commitment to having at least 20% of the combined company's total research and development workforce in the UK, with Chief Executive Ian Read telling UK politicians on the House of Commons' Committee for Business, Innovation and Skills that "I'm a man of my word".

Separately Tuesday, AstraZeneca put out positive results from a drugs trial, the second day in a row that it has put out positive data. One of the company's arguments for staying independent is that it has a much improved pipeline of potential new drugs.

It said a phase III study of combination treatment saxagliptin and dapagliflozin for the treatment of type 2 diabetes showed that patients treated with the combination in addition to metaformin, saw a significant reduction in glycated haemoglobin, a key indicator in the control of diabetes.

The drugs pipeline news wasn't so positive for GlaxoSmithKline, the biggest of the UK's pharmaceuticals companies. It said its phase III study for darapladib in the treatment of acute coronary syndrome failed to meet its primary endpoint of reducing major coronary events compared to a placebo when added to standard care.

--------
FTSE 100: up 0.1% at 6,856.86
FTSE 250: up 0.2% at 16,016.74
AIM ALL-SHARE: up 0.1% at 809.50
GBP-USD: down at 1.6852
EUR-USD: down at 1.3722
GOLD: up at USD1,296.56 an ounce
OIL (Brent): up at USD108.73 a barrel
--------

Key UK Corporate News

--------
FTSE 100: London Stock Exchange Group says it is evaluating the merits of a potential acquisition of Frank Russell Co, the asset management and investment services arm of The Northwestern Mutual Life Insurance Company which also owns Russel Global Indexes. It's facing tough competition if it decides to make an offer, according to reports. TUI Travel said it narrowed its pretax loss in the first half of its financial year, despite the later timing of the key Easter trading period, boosted by strong trading in the UK and Germany and demand for its all-inclusive packages, as well as cost reductions as it reined in losses from its French business. easyJet's pretax loss also narrowed in the six months to the end of March as revenue rose and the mild winter reduced the need for costly de-icing of its planes and reduced disruption. Old Mutual's majority-owned South African banking subsidiary, Nedbank Group Ltd, has reported growth in net interest income and non-interest revenue in the first quarter. Melrose Industries is confident it will meet full-year expectations, after it saw order intake rise 3% in the year to date.

FTSE 250: Taylor Wimpey has set itself challenging new financial targets for the next three years, spurred on by the recovery in the UK housing market. It expects to deliver an operating margin increase of at least 300 basis points in 2014 and a return on net operating assets of at least 20%. In the following three years, it wants to achieve an average operating margin of 20% and a return on net operating assets of at least 20% a year, and an average increase in net assets of 15% a year. It hopes to convert at least 65% of operating profit into operating cashflow over the period. Enterprise Inns posted a first-half pretax profit of GBP47 million, up from GBP29 million the prior year, helped by lower exceptional property charges, and a return to like-for-like net income growth. Revenues for the period decreased slightly as a result of selling off pubs. Brewin Dolphin expects to take an "exceptional" pretax impairment charge of about GBP32.0 million in the second-half of the year after deciding against implementing the Figaro software system into its discretionary wealth management business. Interserve says it is trading in line with expectations in 2014, boosted by a number of contract wins from clients including the UK Department for Education, Christie NHS Foundation, and the Foreign & Commonwealth Office. National Express also says trading since the beginning of the year has been positive overall, and it's on track to deliver on its earnings expectations for the full-year thanks to growth in its UK bus and rail operations.

AIM All-Share: Crawshaw Group is doing well after it acquired East Yorkshire Beef Ltd, a single-site, high-end butcher, a move it says marks it entry into the premium meat market. It didn't give financial details, but WH Ireland understands that it cost about GBP220,000. Egdon Resources is up after it said it will pay for Alkane Energy's shale assets by issuing 40 million shares, and it confirmed a placing and open offer to raise up to GBP7 million to fund increased capital commitments. Hayward Tyler Group is another gainer after it said new orders for its financial year to the end of March were up 8% on the year, and it expects full-year results to meet market expectations. Red Rock Resources is up after it executed a binding letter of intent to sell its Colombian interests to Nicaragua Milling Company Ltd for up to USD5 million. Lombard Risk Management is doing well after it reported a 13% increase in full-year pretax profit, thanks to a jump in revenue driven by increased regulation on financial services firms that's pushing up demand for its software. The profit increase lagged its revenue rise as it hired experienced senior sales executives that it hopes will drive further growth. It's continuing to search for a new chief financial officer. Strategic Natural Resources has fallen sharply after it said it had secured an investment of GBP1.5 million in the company at a price per share below the market rate, secured a deal to pay off at least one creditor, and said it will appoint several new executives to run the company. The money it is raising will not be enough to pay off all the money it owes its current creditors, but the company said it was continuing talks about other funding options. It has signed a settlement deal with London Commodity Brokers. Totally is down after its pretax loss widened to GBP731,000 in 2013, from GBP679,000 in 2012, as higher costs offset a revenue rise. However, it expressed confidence for this year after cutting costs and overheads following a strategic review. Tangiers Petroleum is down after it said it plans to raise AUD5 million through a private share placing to help fund drilling of the TAO-1 well in Morocco.
---------
Top Economics And General
----------
UK retail sales surged in April from the prior year on Easter spending, data from the British Retail Consortium showed. Retail sales advanced 4.2% on a like-for-like basis in April from a year ago, when they had decreased 2.2%. On a total basis, sales were up 5.7%, compared to a 0.6% fall in April 2013. According to BRC, furniture and flooring was the best performing category, reporting its highest growth since Easter 2006.
----------
Germany's economic expectations worsened more-than-expected in May, a closely watched survey showed. The economic sentiment index fell to 33.1 in May from 43.2 in April, the Mannheim-based Centre for European Economic Research said. The score was forecast to fall to 40. "Already, there are indications that Germany will not be able to maintain this fast pace of growth," ZEW President Clemens Fuest said. "Nevertheless, one can assume a positive underlying trend for the economic development for the year 2014."
----------
China's industrial production growth eased unexpectedly in April, data showed. Retail sales also expanded at a slower pace in April. Industrial production grew 8.7% year-on-year in April, which was slightly slower than the 8.8% rise seen in March, the National Bureau of Statistics said. Production was forecast to rise by 8.9%. Retail sales advanced 11.9% in April from a year ago, while the growth was forecast to remain unchanged at 12.2%.
----------
The self-declared People's Republic of Donetsk on Monday asked to leave Ukraine and join the Russian Federation, a day after a hastily arranged secession referendum that has been declared illegal by Western governments. Denis Pushilin, a leader of the separatist movement in eastern Ukraine, declared the region's independence. His movement said that an overwhelming majority in the country's east voted in favour of secession.
----------
UN Secretary General Ban Ki-moon called for a special tribunal "with international involvement" to investigate atrocities committed in South Sudan after a UN report last week found that violence by all sides may constitute crimes against humanity. "I have requested the Security Council to consider to establish a hybrid or international tribunal," Ban said. "We have found crimes against humanity by both sides...Those perpetrators have to be held accountable, this is a fundamental principle of international human rights law."
----------
US Secretary of State John Kerry is to meet Palestinian President Mahmoud Abbas Thursday in London on the sidelines of the Syrian support group gathering. "While the door remains open to the peace process, the purpose of the meeting is to discuss our ongoing relationship with the Palestinians," State Department spokeswoman Jen Psaki said Monday. Earlier in the day, EU foreign ministers pledged they would support a new Palestinian government on condition it is committed to peace talks with Israel. Fatah, which controls the West Bank, and the radical Islamist Hamas movement, which dominates the Gaza Strip, agreed late last month to form a transitional unity government and hold elections by November.
----------
The European Court of Human Rights has ordered the Turkish government to pay EUR90 million in damages for human rights abuses over its occupation of northern Cyprus. The decision marks the largest sum ever awarded by the European Court of Human Rights in a case concerning Cypriot refugees and the 1974 invasion of the island.
----------
Syria has condemned what it said are moves by France and Germany to block its citizens from voting in upcoming presidential elections, the crisis-stricken country's foreign ministry said on Monday. Accusing the two countries of supporting terrorism, the ministry said in statements carried by the official SANA news agency that they "must know that Syria is an independent, sovereign state and its decisions emanate from the will of its people."
----------
Islamist extremist sect Boko Haram said it is willing to negotiate with Nigeria's government over the release of more than 200 schoolgirls it abducted four weeks ago. The group released a video Monday demanding the release of all imprisoned insurgents in Nigeria in exchange for the teenagers.
----------

Afternoon Watchlist (all times British Summer Time)

15:00 US Business Inventories

--------

Wednesday's Key UK Corporate Events

AstraZeneca Astra/Pfizer Executives Testify In UK Parliament
Premier Oil Interim Management Statement
Rathbone Brothers Interim Management Statement
UDG Full Year Results
British Land Co Full Year Results
ICAP Full Year Results
New World Resources Q1 Results
Informa Interim Management Statement
Admiral Group Interim Management Statement
Novae Group Interim Management Statement
Mondi Interim Management Statement
Renishaw Interim Management Statement
Galliford Try Interim Management Statement
London Mining Interim Management Statement
Catlin Group Interim Management Statement
Alpha UK Multi Property Trust Interim Management Statement
Compass Group Half Year Results
Hill & Smith Holdings Interim Management Statement
Hilton Food Group Interim Management Statement
ITV Interim Management Statement
Marshalls Interim Management Statement
John Wood Group Interim Management Statement
3i Group Full Year Results
Partnership Assurance Interim Management Statement

-------

Wednesday's Key Economic Events (all times British Summer Time)

00:50 Japan Domestic Corporate Goods Price Index
07:00 Germany Consumer Price Index
07:00 Japan Machine Tool Orders
07:45 France Consumer Price Index
09:30 UK ILO Unemployment Rate
10:00 EU Industrial Production
10:30 UK Bank of England Quarterly Inflation Report
12:00 US MBA Mortgage Applications
13:30 US Producer Price Index
15:30 US EIA Crude Oil Stocks change

-------

By Steve McGrath; steve.mcgrath@alliancenews.com; @stevemcgrath1

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.